Biopharma Science Whitepapers | Page 4

Whitepaper

Advances in Cell Therapy

This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.

Whitepaper

Enhancing Immune Cell Cytotoxicity and Persistence Insights Using Real-Time Cell Analysis

Cell therapies, from regenerative medicine to immunotherapy, are transforming the medical landscape with 75 already approved globally and over 2,000 in development.

A scientist uses a pipette while wearing blue gloves. The image is overlaid with white dots and lines to represent a network.

Whitepaper

Embracing Data-Driven Modeling Approaches Into Biopharmaceutical Processing

This article explores new workflows using data-driven modeling to improve culture medium and new control algorithms allowing for better modulation within the bioprocess design space.

Gloved hands hold an agar dish and a cotton swab. In the background other agar dishes and a test tube rack can be seen.

Whitepaper

Cell Culture – Good Practice and Advanced Methods

This article explores how quality control can improve protocol standardization, enhance scalability and ensure that cultures meet regulatory criteria.

Clear glass vials filled with a colourless liquid sit on a conveyor belt.

Whitepaper

Applications of Mass Spectrometry in Biopharmaceutical Analysis

The sensitivity and specificity of mass spectrometry (MS) has made it an indispensable tool for biopharmaceutical analysis, ensuring the safety and efficacy of biologics.

Whitepaper

Techniques for Oligonucleotide Analysis

This article presents current techniques in oligonucleotide production and characterization, highlighting recent advancements that enhance the efficiency of these methods

Whitepaper

Heralding a New Era of RNA Therapeutics

This article explores how scientists are tackling the challenges and intensifying efforts to develop mRNA therapeutics for different diseases.

Whitepaper

Novel CAR Technology To Transform Cancer Therapy

Chimeric antigen receptor (CAR) therapies involve the use of engineered receptors capable of redirecting immune cells to recognize and destroy cancer cells expressing a specific antigen. Currently, CAR T cells dominate the field of CAR therapy.

Whitepaper

Select Better Antibodies Using NGS Data

This whitepaper explores the cutting-edge cloud-based antibody selection tools, that provide confident and timely antibody selection. It also highlights the latest analysis software for independent, intricate analyses and optimal antibody selection.